ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Safranal improves the anticancer efficacy of sorafenib via transcriptomic reprogramming and metabolomic changes in a rat model of diethylnitrosamine-induced cirrhosis-hepatocellular carcinoma.

Ameera Al Mansoori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.